Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies

被引:112
作者
Jeannin, P
Magistrelli, G
Goetsch, L
Haeuw, JF
Thieblemont, N
Bonnefoy, JY
Delneste, Y
机构
[1] Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France
[2] Hop Necker Enfants Malad, CNRS, UMR 8603, F-75743 Paris, France
关键词
outer membrane protein A; cytotoxic T cells; dendritic cells; vaccine;
D O I
10.1016/S0264-410X(02)00383-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outer membrane protein A (OmpA) is a class of proteins highly conserved among the Enterobacteriaceae family and throughout evolution. We have observed that antigen presenting cells (APCs) recognize and are activated by the recombinant OmpA from Klebsiella pneumoniae (KpOmpA). KpOmpA triggers cytokine production by macrophages and dendritic cells (DC), induces DC maturation and signals via Toll-like receptor 2. KpOmpA also interacts with endocytic receptor(s) expressed on DC and macrophages. Tumor antigens coupled to KpOmpA are taken up by APCs and gain access to the MHC class I pathway, triggering the initiation of protective anti-tumor cytotoxic responses in the absence of CD4 T cell help and adjuvant. Thus, OmpA appears as a new type of pathogen-associated molecular pattern (PAMP) usable as a vector in anti-infectious and therapeutic anti-tumor vaccines to elicit CTLs. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:A23 / A27
页数:5
相关论文
共 31 条
[1]   Mechanisms of phagocytosis in macrophages [J].
Aderem, A ;
Underhill, DM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :593-623
[2]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[3]   Fcγ receptors and cross-presentation in dendritic cells [J].
Amigorena, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :F1-F3
[4]  
Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645
[5]   Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses [J].
Apostolopoulos, V ;
Barnes, N ;
Pietersz, GA ;
McKenzie, IFC .
VACCINE, 2000, 18 (27) :3174-3184
[6]   Dendritic cells as vectors for therapy [J].
Banchereau, J ;
Schuler-Thurner, B ;
Palucka, AK ;
Schuler, G .
CELL, 2001, 106 (03) :271-274
[7]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[8]   Stability and CTL-activity of P40/ELA melanoma vaccine candidate [J].
Beck, A ;
Goetsch, L ;
Champion, T ;
Bussat, MC ;
Aubry, JP ;
Klinguer-Hamour, C ;
Haeuw, JF ;
Bonnefoy, JY ;
Corvaïa, N .
BIOLOGICALS, 2001, 29 (3-4) :293-298
[9]   Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein a derived from Klebsiella pneumoniae [J].
Goetsch, LN ;
Gonzalez, A ;
Plotnicky-Gilquin, H ;
Haeuw, JF ;
Aubry, JP ;
Beck, A ;
Bonnefoy, JY ;
Corvïa, N .
INFECTION AND IMMUNITY, 2001, 69 (10) :6434-6444
[10]   Antigen presentation and T cell stimulation by dendritic cells [J].
Guermonprez, P ;
Valladeau, J ;
Zitvogel, L ;
Théry, C ;
Amigorena, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :621-667